These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7909847)

  • 1. Investigation of the active site of aminopeptidase A using a series of new thiol-containing inhibitors.
    Chauvel EN; Coric P; Llorens-Cortès C; Wilk S; Roques BP; Fournié-Zaluski MC
    J Med Chem; 1994 Apr; 37(9):1339-46. PubMed ID: 7909847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential inhibition of aminopeptidase A and aminopeptidase N by new beta-amino thiols.
    Chauvel EN; Llorens-Cortès C; Coric P; Wilk S; Roques BP; Fournié-Zaluski MC
    J Med Chem; 1994 Sep; 37(18):2950-7. PubMed ID: 7915326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminopeptidase A, which generates one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, has a key role in central control of arterial blood pressure.
    Reaux A; Iturrioz X; Vazeux G; Fournie-Zaluski MC; David C; Roques BP; Corvol P; Llorens-Cortes C
    Biochem Soc Trans; 2000; 28(4):435-40. PubMed ID: 10961935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent and selective inhibition of zinc aminopeptidase A (EC 3.4.11.7, APA) by glutamyl aminophosphinic peptides: importance of glutamyl aminophosphinic residue in the P1 position.
    Georgiadis D; Vazeux G; Llorens-Cortes C; Yiotakis A; Dive V
    Biochemistry; 2000 Feb; 39(5):1152-5. PubMed ID: 10653662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent and systemically active aminopeptidase N inhibitors designed from active-site investigation.
    Fournié-Zaluski MC; Coric P; Turcaud S; Bruetschy L; Lucas E; Noble F; Roques BP
    J Med Chem; 1992 Apr; 35(7):1259-66. PubMed ID: 1348542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of angiotensin III formation by thiol derivatives of acidic amino acids.
    Wilk S; Thurston LS
    Neuropeptides; 1990 Jul; 16(3):163-8. PubMed ID: 1982017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release.
    Zini S; Fournie-Zaluski MC; Chauvel E; Roques BP; Corvol P; Llorens-Cortes C
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11968-73. PubMed ID: 8876246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PC18, a specific aminopeptidase N inhibitor, induces vasopressin release by increasing the half-life of brain angiotensin III.
    Réaux A; de Mota N; Zini S; Cadel S; Fournié-Zaluski MC; Roques BP; Corvol P; Llorens-Cortès C
    Neuroendocrinology; 1999 May; 69(5):370-6. PubMed ID: 10343178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histidine 450 plays a critical role in catalysis and, with Ca2+, contributes to the substrate specificity of aminopeptidase A.
    Iturrioz X; Vazeux G; Célérier J; Corvol P; Llorens-Cortès C
    Biochemistry; 2000 Mar; 39(11):3061-8. PubMed ID: 10715127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Identification of metabolic pathways of brain angiotensin II and angiotensin III: predominant role of angiotensin III in the control of vasopressin secretion].
    Llorens-Cortes C
    C R Seances Soc Biol Fil; 1998; 192(4):607-18. PubMed ID: 9842467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell surface aminopeptidase A and N activities in human glomerular epithelial cells.
    Stefanovic V; Vlahovic P; Ardaillou N; Ronco P; Ardaillou R
    Kidney Int; 1992 Jun; 41(6):1571-80. PubMed ID: 1354270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asp218 participates with Asp213 to bind a Ca2+ atom into the S1 subsite of aminopeptidase A: a key element for substrate specificity.
    Claperon C; Rozenfeld R; Iturrioz X; Inguimbert N; Okada M; Roques B; Maigret B; Llorens-Cortes C
    Biochem J; 2008 Nov; 416(1):37-46. PubMed ID: 18598240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A tyrosine residue essential for catalytic activity in aminopeptidase A.
    Vazeux G; Iturrioz X; Corvol P; Llorens-Cortès C
    Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):883-9. PubMed ID: 9581570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of asparagine 353 in aminopeptidase A: characterization of a novel motif (GXMEN) implicated in exopeptidase specificity of monozinc aminopeptidases.
    Iturrioz X; Rozenfeld R; Michaud A; Corvol P; Llorens-Cortes C
    Biochemistry; 2001 Dec; 40(48):14440-8. PubMed ID: 11724556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new strategy for treating hypertension by blocking the activity of the brain renin-angiotensin system with aminopeptidase A inhibitors.
    Gao J; Marc Y; Iturrioz X; Leroux V; Balavoine F; Llorens-Cortes C
    Clin Sci (Lond); 2014 Aug; 127(3):135-48. PubMed ID: 24697296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and in vitro activities of new non-peptidic APA inhibitors.
    Inguimbert N; Coric P; Dhotel H; Bonnard E; Llorens-Cortes C; Mota N; Fournié-Zaluski MC; Roques BP
    J Pept Res; 2005 Feb; 65(2):175-88. PubMed ID: 15705162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silver(I)/6-hydroxyiminolumazine compounds differently modify renin-angiotensin system-regulating aminopeptidases A and N in human neuroblastoma and glioma cells.
    Ramírez-Expósito MJ; Mayas-Torres MD; Carrera-González MP; Jiménez-Pulido SB; Illán-Cabeza NA; Sánchez-Sánchez P; Hueso-Ureña F; Martínez-Martos JM; Moreno-Carretero MN
    J Inorg Biochem; 2014 Sep; 138():56-63. PubMed ID: 24892514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating aminopeptidase activities in men and women with essential hypertension.
    Sánchez-Agesta Ortega R; Arias de Saavedra-Alías JM; Liébana-Cañada A; Sánchez-Muñoz B; Martínez-Martos JM; Ramírez-Expósito MJ
    Curr Med Chem; 2013; 20(38):4935-45. PubMed ID: 23931276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A glutamate residue contributes to the exopeptidase specificity in aminopeptidase A.
    Vazeux G; Iturrioz X; Corvol P; Llorens-Cortes C
    Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):407-13. PubMed ID: 9716499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of subsite preferences in aminopeptidase A (EC 3.4.11.7) led to the design of the first highly potent and selective inhibitors of this enzyme.
    David C; Bischoff L; Meudal H; Mothé A; De Mota N; DaNascimento S; Llorens-Cortes C; Fournié-Zaluski MC; Roques BP
    J Med Chem; 1999 Dec; 42(25):5197-211. PubMed ID: 10602705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.